FNY Investment Advisers’s Epizyme, Inc EPZM Stock Holding History

FNY Investment Advisers’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-50,000	Closed	-$73K	–	968
2022 Q2	$73K	Buy	+50,000	New	+$36.7K	0.05%	192

Other funds holding EPZM

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

FNY Investment Advisers's EPZM Position: Q3 2022 in Review

FNY Investment Advisers sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 50,000 shares — an estimated $73K sold.

FNY Investment Advisers first reported a position in EPZM in Q2 2022 and held it in 1 quarter. The position peaked at $73K in Q2 2022. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.

FNY Investment Advisers reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
FNY Investment Advisers sold 50,000 Epizyme, Inc shares in Q3 2022, an estimated $73K.
FNY Investment Advisers first reported a position in Epizyme, Inc in Q2 2022 and held it in 1 quarter.
FNY Investment Advisers's Epizyme, Inc position peaked at $73K in Q2 2022.
0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.

Based on FNY Investment Advisers's 13F filing for Q3 2022, filed 19 Oct 2022.